BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CSA Medical, Inc. Appoints William H. Floyd President and CEO


12/2/2010 11:12:48 AM

BALTIMORE, Dec. 2, 2010 /PRNewswire/ -- CSA Medical, Inc. (www.CSAmedical.com) today announced the appointment of William H. Floyd as incoming president, CEO and member of the board of directors. Floyd brings to the company more than 20 years of medical device experience, including market development roles commercializing disposables, implants, capital equipment and monitoring systems.

"We are thrilled to have Bill join the company and lead our efforts to create a world class medical device company," said Vince Owens, Chairman of the CSA Medical board of directors. "The company has made steady progress growing our customer and procedure base, and we believe that Bill has the background and experience needed to take our business to the next level of commercialization, including leading product development, clinical trials, regulatory, sales and marketing."

Prior to joining CSA Medical, Bill served as vice president of U.S. sales for Covidien following the sale of Aspect Medical Systems to Covidien in 2009. Previously, he was executive vice president of worldwide sales and marketing at Aspect Medical Systems, Inc. Throughout a seven-year period, he managed Aspect from $19 million in revenue and a $20 million operating loss to more than $110 million in revenue and $16 million operating profit. Earlier in his career, Bill spent five years serving as vice president of marketing at Boston Scientific. In this position, he developed and executed the urology division's five year strategic plan focused on growth and diversification. His efforts led to two acquisitions and numerous licensing and distribution agreements. Previously, Bill held numerous senior sales and marketing positions with Johnson & Johnson (Codman & Shurtleff) and Procter and Gamble. Bill earned a bachelor's degree from the University of Vermont.

"CSA Medical's spray cryotherapy is a tremendously exciting new technology that holds promise to stop disease processes and dramatically improve the quality of life for millions of patients," said Floyd. "I look forward to working with our team to bring the benefits of this technology to more patients across the globe as we expand our customer and procedure base."

CSA Medical, Inc develops and manufactures a proprietary therapeutic interventional treatment platform, the CryoSpray Ablation System, that delivers therapeutic doses of a cryogen to flash freeze and destroy diseased tissue inside the body. The Company is the first to harness the power of extreme cold (-196 C) liquid nitrogen therapeutic energy delivery inside the body. To learn more, please visit www.CSAmedical.com.

SOURCE CSA Medical, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES